Pharmaceutical preparations company · DE · FY ends Dec · -$64M FCF
Revenue declined 100.0% YoY. The question is whether this is cyclical or a structural shift.
ROIC dropped from -6.95% to -22.06%, capital efficiency is deteriorating. Negative free cash flow of -$60M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$0.00
▼ -100.0% YoY
Net Income (TTM)
-$76M
▼ -670.0% YoY
Op. Margin
—
ROIC
-24.38%
▼ -15.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$64M
▼ -2319.0% YoY
Op. Cash Flow (TTM)
-$64M
▼ -2608.1% YoY
Net Debt
-$44M
Net Cash Position
Cash & Equiv.
$50M
Continue Research